Correlation of the Severity of Atopic Dermatitis and Serum IgE Levels
DOI:
https://doi.org/10.70749/ijbr.v3i3.802Keywords:
Atopic Dermatitis, Serum IgE Levels, Rajka and Langeland ScoreAbstract
Background: Atopic dermatitis is a chronic, relapsing inflammatory skin condition characterised by intense itching. The condition is often linked to other atopic disorders in the individual or among family members and is linked with elevated serum IgE levels. This study aims to investigate the correlation between the severity of atopic dermatitis (AD) and serum IgE levels specifically within the Pakistani population. Methods: A cross-sectional study was conducted involving the enrolment of 53 patients in the Department of Dermatology and department of chemical pathology Army Medical College lab in Pakistan Emirates Military Hospital from May 2024 to October 2024. Patients were categorised into three groups: mild (3–4), moderate (4.5–7.5), or severe (8–9), with ages ranging from 1 to 40 years. A one-way ANOVA was employed to assess the mean difference in serum IgE levels relative to the severity of atopic dermatitis, with a significance level of p ≤ 0.05 deemed statistically significant. Results: The study involved 53 participants, with a mean age of 11.2 years (SD ± 6.6). The cohort comprised 21 males (39.6%) and 32 females (60.4%). The mean serum IgE level was 230.4 IU/mL (SD ± 120.3). Participants were classified into three groups based on symptom severity: 18 (33.9%) with mild symptoms (scores 3–4), 21 (39.6%) with moderate symptoms (scores 4.5–7.5), and 14 (26.5%) with severe symptoms (scores 8–9). The mean serum IgE levels were 153.9 IU/mL (SD ± 49.7) in the mild group, 217.1 IU/mL (SD ± 113.5) in the moderate group, and 319.5 IU/mL (SD ± 197.8) in the severe group, with a statistically significant p-value of 0.001. Conclusion: Serum IgE is a valuable indicator for predicting the severity of atopic dermatitis in younger patients.
Downloads
References
Lee, J. H., Yun, S., Lee, J., & Lee, S. (2020). Therapeutic efficacy and safety of methotrexate in moderate-to-Severe atopic dermatitis: A retrospective study of Korean patients at tertiary referral hospital. Annals of Dermatology, 32(5), 402. https://doi.org/10.5021/ad.2020.32.5.402
Flohr, C., & Mann, J. (2013). New insights into the epidemiology of childhood atopic dermatitis. Allergy, 69(1), 3-16. https://doi.org/10.1111/all.12270
Mortimer, K., Lesosky, M., García-Marcos, L., Asher, M. I., Pearce, N., Ellwood, E., Bissell, K., El Sony, A., Ellwood, P., Marks, G. B., Martínez-Torres, A., Morales, E., Perez-Fernandez, V., Robertson, S., Rutter, C. E., Silverwood, R. J., Strachan, D. P., & Chiang, C. (2022). The burden of asthma, hay fever and eczema in adults in 17 countries: GAN phase I study. European Respiratory Journal, 60(3), 2102865. https://doi.org/10.1183/13993003.02865-2021
Weidinger, S., & Schreiber, S. (2020). Abrocitinib for atopic dermatitis: A step forward. The Lancet, 396(10246), 215-217. https://doi.org/10.1016/s0140-6736(20)31284-8
Egawa, G., & Kabashima, K. (2016). Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. Journal of Allergy and Clinical Immunology, 138(2), 350-358.e1. https://doi.org/10.1016/j.jaci.2016.06.002
Bin, L., & Leung, D. Y. (2016). Genetic and epigenetic studies of atopic dermatitis. Allergy, Asthma & Clinical Immunology, 12(1). https://doi.org/10.1186/s13223-016-0158-5
Yang, G., Seok, J. K., Kang, H. C., Cho, Y., Lee, H. S., & Lee, J. Y. (2020). Skin barrier abnormalities and immune dysfunction in atopic dermatitis. International Journal of Molecular Sciences, 21(8), 2867. https://doi.org/10.3390/ijms21082867
Nakatsuji, T., Cheng, J. Y., & Gallo, R. L. (2021). Mechanisms for control of skin immune function by the microbiome. Current Opinion in Immunology, 72, 324-330. https://doi.org/10.1016/j.coi.2021.09.001
Hu, Y., Liu, S., Liu, P., Mu, Z., & Zhang, J. (2020). Clinical relevance of eosinophils, basophils, serum total Ige level, allergen‐specific Ige, and clinical features in atopic dermatitis. Journal of Clinical Laboratory Analysis, 34(6). https://doi.org/10.1002/jcla.23214
Ibrahim, H. M., El-Taieb, M. A., Hassan, M. H., Mohamed, A. A., Kotop, E. A., Abd-ellah, O. H., & Hegazy, E. M. (2020). Relations between vitamin D3, total and specific Ige for house dust mites in atopic dermatitis patients. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-77968-1
Silverberg, J., Lei, D., Yousaf, M., Janmohamed, S., Vakharia, P., Chopra, R., Chavda, R., Gabriel, S., Patel, K., Singam, V., Kantor, R., & Hsu, D. Y. (2020). Measurement properties of the rajka–langeland severity score in children and adults with atopic dermatitis*. British Journal of Dermatology, 184(1), 87-95. https://doi.org/10.1111/bjd.19159
Ishizaka, K., Ishizaka, T., & Hornbrook, M. M. (1967). Allergen-binding activity of γE, γG and γA antibodies in sera from atopic patients. The Journal of Immunology, 98(3), 490-501. https://doi.org/10.4049/jimmunol.98.3.490
Wide, L., Bennich, H., & Johansson, S. (1967). Diagnosis of allergy by an in-vitro test for allergen antibodies. The Lancet, 290(7526), 1105-1107. https://doi.org/10.1016/s0140-6736(67)90615-0
HOFFMAN, D., YAMAMOTO, F., GELLER, B., & HADDAD, Z. (1975). Specific Ige antibodies in atopic eczema. Journal of Allergy and Clinical Immunology, 55(4), 256-267. https://doi.org/10.1016/0091-6749(75)90145-1
MCGEADY, S., & BUCKLEY, R. (1975). Depression of cell-mediated immunity in atopic eczema. Journal of Allergy and Clinical Immunology, 56(5), 393-406. https://doi.org/10.1016/0091-6749(75)90133-5
ORGEL, H., HAMBURGER, R., BAZARAL, M., GORRIN, H., GROSHONG, T., LENOIR, M., MILLER, J., & WALLACE, W. (1975). Development of Ige and allergy in infancy. Journal of Allergy and Clinical Immunology, 56(4), 296-307. https://doi.org/10.1016/0091-6749(75)90104-9
Cookson, W. O., Ubhi, B., Lawrence, R., Abecasis, G. R., Walley, A. J., Cox, H. E., Coleman, R., Leaves, N. I., Trembath, R. C., Moffatt, M. F., & Harper, J. I. (2001). Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nature Genetics, 27(4), 372-373. https://doi.org/10.1038/86867
Bunikowski, R., Mielke, M., Skarabis, H., Herz, U., Bergmann, R. L., Wahn, U., & Renz, H. (1999). Prevalence and role of serum Ige antibodies to the staphylococcus aureus–derived superantigens SEA and SEB in children with atopic dermatitis. Journal of Allergy and Clinical Immunology, 103(1), 119-124. https://doi.org/10.1016/s0091-6749(99)70535-x
SICHERER, S., & SAMPSON, H. (1999). Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management. Journal of Allergy and Clinical Immunology, 104(3), S114-S122. https://doi.org/10.1016/s0091-6749(99)70053-9
Osawa, R., Akiyama, M., & Shimizu, H. (2011). Filaggrin gene defects and the risk of developing allergic disorders. Allergology International, 60(1), 1-9. https://doi.org/10.2332/allergolint.10-rai-0270
Wang, I., Lin, T., Kuo, C., Lin, S., Lee, Y., & Chen, P. (2011). Filaggrin polymorphism P478S, Ige level, and atopic phenotypes. British Journal of Dermatology, 164(4), 791-796. https://doi.org/10.1111/j.1365-2133.2011.10212.x
Liu, F., Goodarzi, H., & Chen, H. (2011). Ige, mast cells, and eosinophils in atopic dermatitis. Clinical Reviews in Allergy & Immunology, 41(3), 298-310. https://doi.org/10.1007/s12016-011-8252-4
Ahmed, I., & Nasreen, S. (2007). Frequency of raised serum IgE level in childhood atopic dermatitis. JPMA. The Journal of the Pakistan Medical Association, 57(9), 431.
Dhar, S., Malakar, R., Chattopadhyay, S., Dhar, S., Banerjee, R., & Ghosh, A. (2005). Correlation of the severity of atopic dermatitis with absolute eosinophil counts in peripheral blood and serum Ige levels. Indian Journal of Dermatology, Venereology and Leprology, 71(4), 246. https://doi.org/10.4103/0378-6323.16615
JOHNSON, E., IRONS, J., PATTERSON, R., & ROBERTS, M. (1974). Serum IgE concentration in atopic dermatitis: relationship to severity of disease and presence of atopic respiratory disease. Journal of Allergy and Clinical Immunology, 54(2), 94-99. https://doi.org/10.1016/0091-6749(74)90037-2
Schäfer, T., Heinrich, J., Wjst, M., Adam, H., Ring, J., & Wichmann, H. (1999). Association between severity of atopic eczema and degree of sensitization to aeroallergens in schoolchildren. Journal of Allergy and Clinical Immunology, 104(6), 1280-1284. https://doi.org/10.1016/s0091-6749(99)70025-4
Laske, N., & Niggemann, B. (2004). Does the severity of atopic dermatitis correlate with serum Ige levels? Pediatric Allergy and Immunology, 15(1), 86-88. https://doi.org/10.1046/j.0905-6157.2003.00106.x
Illi, S., Von Mutius, E., Lau, S., Nickel, R., Grüber, C., Niggemann, B., Wahn, U., & The Multicenter Allergy Study Gro. (2004). The natural course of atopic dermatitis from birth to age 7 years and the association with asthma☆. Journal of Allergy and Clinical Immunology, 113(5), 925-931. https://doi.org/10.1016/j.jaci.2004.01.778
Somani, V. (2008). A study of allergen-specific Ige antibodies in Indian patients of atopic dermatitis. Indian Journal of Dermatology, Venereology and Leprology, 74(2), 100. https://doi.org/10.4103/0378-6323.39689
Hon, K. E., Lam, M. A., Leung, T., Wong, K., Chow, C., Fok, T., & Ng, P. (2007). Are age‐specific high serum Ige levels associated with worse symptomatology in children with atopic dermatitis? International Journal of Dermatology, 46(12), 1258-1262. https://doi.org/10.1111/j.1365-4632.2007.03407.x
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
